HIV-negative men who receive pre-exposure prophylaxis with tenofovir and emtricitabine do not develop resistance to these drugs, according to new findings.
In this study, the researchers examined adipose tissue changes of men with HIV who were taking cART to determine whether diagnosing metabolic syndrome rather than lipodystrophy is better for cardiometabolic...
In a new study, researchers examined whether HIV is independently associated with abdominal obesity, elevated LDL-C, hypertriglyceridemia, and hypertension.
In an attempt to decrease transmission of HIV and end the current epidemic, major stakeholders are taking steps to increase availability of pre-exposure prophylaxis, although some plans still deny...
With the risk for tenofovir nephrotoxicity in mind, researchers investigated the impact of treatment with sofosbuvir/ledipasvir with or without tenofovir in patients with HCV/HIV coinfection.
Comorbidities like hepatitis C virus, renal, liver, and chronic pulmonary diseases significantly boosted the risk of hospitalization and costs of patients with HIV, a recent study suggests.
The International Antiviral Society–USA Panel has released a set of updated recommendations for the treatment of patients with HIV, including universal screening for anyone who has been sexually active and...
